CCL
67
2
HST
52
-2
TXN
65
-3
AMAT
63
-3
GLW
49
3
EFX
50
3
JCI
70
2
DE
56
3
EQR
37
3
R
62
-4
HON
72
2
DOV
52
2
ECL
59
5
O
35
2
PCG
50
5
VNO
52
3
MTB
53
-4
RHI
27
2
MCK
52
2
PHM
46
3
CCL
67
2
HST
52
-2
TXN
65
-3
AMAT
63
-3
GLW
49
3
EFX
50
3
JCI
70
2
DE
56
3
EQR
37
3
R
62
-4
HON
72
2
DOV
52
2
ECL
59
5
O
35
2
PCG
50
5
VNO
52
3
MTB
53
-4
RHI
27
2
MCK
52
2
PHM
46
3
Financhill
Back

Ascendis Pharma AS Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
33

ASND
Ascendis Pharma AS

Last Price:
$177.09
Seasonality Move:
11.48%

7 Day Trial

ALL ACCESS PASS

$ 7

Ascendis Pharma AS Stock Forecast

  • Over the next 52 weeks, Ascendis Pharma AS has on average historically risen by 36.3% based on the past 10 years of stock performance.
  • Ascendis Pharma AS has risen higher in 6 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
  • Is Ascendis Pharma AS Stock Undervalued?
    The current Ascendis Pharma AS [ASND] share price is $175.40. The Score for ASND is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • ASND is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Ascendis Pharma AS Stock Go Up Next Year?

  • Over the next 52 weeks, Ascendis Pharma AS has on average historically risen by 36.3% based on the past 10 years of stock performance.

Ascendis Pharma AS Stock Rating

Sell
33
Ascendis Pharma AS (ASND) is a Sell

Is Ascendis Pharma AS overpriced?

  • Ascendis Pharma AS has risen higher in 6 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%

Ascendis Pharma AS Stock Price History

Is ASND stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ASND is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
Denmark
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
ascendispharma.com

52-Week Data

52-Week High:
183.00
52-Week Low:
111.09

Prediction Charts

Market Cap:
10.6B
Price in USD:
175.40
Volume:
426.4K
Beta:
0.59

Technical Analysis

SMA50:
168.63
SMA100:
162.33
SMA200:
147.32
52-Wk Change:
24.57%

Stock Predictions

  • Is Ascendis Pharma AS stock public?
    Yes, Ascendis Pharma AS is a publicly traded company.
  • What is the Ascendis Pharma AS stock quote today?
    The Ascendis Pharma AS stock price is 175.40 USD today.
  • How to buy Ascendis Pharma AS stock online?
    You can buy Ascendis Pharma AS shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jun-26 174.32 172.95 175.27 172.00
Jun-27 172.66 172.22 174.81 170.67
Jun-30 172.22 172.60 174.31 169.21
Jul-1 170.78 172.00 173.70 167.52
Jul-2 170.19 173.10 174.34 170.19
Jul-3 172.86 174.18 174.39 169.81
Jul-7 174.00 175.98 175.98 170.73
Jul-8 177.48 168.17 178.29 168.01
Jul-9 169.67 175.71 180.00 168.17
Jul-10 175.72 176.49 177.83 172.68
Jul-11 176.42 174.96 177.18 173.78
Jul-14 175.50 174.89 179.50 173.81
Jul-15 176.00 174.75 177.00 171.49
Jul-16 175.00 175.40 176.23 171.10

Ascendis Pharma AS Earnings

Ascendis Pharma AS Earnings Report: Per Share Ascendis Pharma AS Earnings Q1 Q2 Q3 and Q4 last year and next year.

Ascendis Pharma AS Forecast Revenue Growth

Ascendis Pharma AS Stock Analysis: Historical quarterly revenues per share for Ascendis Pharma AS and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.70 per share, an increase next quarter of $0.42 per share, an increase this year of $2.62 per share, and an increase next year of $6.27 per share.

* Ascendis Pharma AS stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.